Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.13819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Hendrika A Segeren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, DNA Replication, Transcription, Genetic, Stress, Physiological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding, ZonMw.
Abstract (Originalsprache)
Oncogene‐induced replication stress (RS) is a vulnerability of cancer cells that forces reliance on the intra‐S‐phase checkpoint to ensure faithful genome duplication. Inhibitors of the intra‐S‐phase checkpoint kinases ATR and CHK1 have been developed, but resistance to these drugs remains problematic. Understanding drug tolerance mechanisms is impeded by analysis of bulk samples, which neglect tumor heterogeneity and often fail to accurately interpret cell cycle‐mediated resistance. Here, by combining intracellular immunostaining and single‐cell RNA‐sequencing, we characterized the transcriptomes of oncogenic RAS‐expressing cells with variable levels of RS when challenged with a CHK1 inhibitor combined with gemcitabine. We identified 37 genes differentially expressed between tolerant and sensitive cells, including several FOXM1 targets. While complete knockdown of FOXM1 impeded cell proliferation, partial knockdown protected cells against DNA damage, and improved recovery from drug‐induced RS. Remarkably, knockdown of individual FOXM1 target genes UBE2C and MKI67 also mitigated DNA damage, uncovering unanticipated roles for these in the replication stress response. Our results suggest that low levels of FOXM1‐dependent gene expression during S and G2 phase protects cells against excessive DNA damage during drug‐induced replication stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
ORCID-Profile: Kathryn A Wierenga, Frank M Riemers, Bart Westendorp
Förderung
- KWF Kankerbestrijding
- ZonMw
Zitieren
APA
Segeren, H. A., Wierenga, K. A., Riemers, F. M., van Liere, E. A., & Westendorp, B. (2025). Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance. Molecular Oncology. https://doi.org/10.1002/1878-0261.13819
Vancouver
Segeren HA, Wierenga KA, Riemers FM, van Liere EA, Westendorp B. Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance. Molecular Oncology. 2025. doi:10.1002/1878-0261.13819
BibTeX
@article{Segeren2025,
author = {Segeren, Hendrika A and Wierenga, Kathryn A and Riemers, Frank M and van Liere, Elsbeth A and Westendorp, Bart},
title = {Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.13819}
}
EUVIMED